Walpar Nutritions Ltd

NSE: WALPAR · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹26.10
Market cap: ₹24.51 Cr
Revenue (annual): ₹78.79 Cr
Net profit (annual): ₹3.00 Cr
P/E (TTM): 8.2×Sector 47.3×
Promoter holding: 68.82%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Results Correction 2 Management Change 2 Board Meeting Outcome 2 Annual General Meeting 2 Price Movement Clarification 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

28 May 2026 18:44 IST NSE

Financial Results

Walpar Nutritions Financial Results

Walpar Nutritions reported standalone annual revenue of ₹65.44 Crore for the financial year 2026. The filing includes audited standalone and consolidated results with an unmodified opinion.

Value: ₹65.44 Cr

Read the filing ↗

28 May 2026 18:35 IST NSE

Financial Results

Walpar Nutritions H2 FY26 Results: Net Profit ₹1.7 Cr, Up 21.4% YoY

Walpar Nutritions Ltd reported revenue from operations of ₹42.3 Cr (+7.9% YoY) and net profit of ₹1.7 Cr (+21.4% YoY) for H2 FY26.

Key figure: Net profit ₹1.7 Cr · +21.4% YoY

Open full results → Read the filing ↗

28 May 2026 18:33 IST NSE

Financial Results

Walpar Nutritions Financial Results

Walpar Nutritions reported audited financial results for the year ended March 31, 2026. The board also appointed new secretarial and internal auditors.

Read the filing ↗